These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 16820616)

  • 1. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery.
    Thielmann M; Leyh R; Massoudy P; Neuhäuser M; Aleksic I; Kamler M; Herold U; Piotrowski J; Jakob H
    Circulation; 2006 Jul; 114(1 Suppl):I441-7. PubMed ID: 16820616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis.
    Massoudy P; Thielmann M; Lehmann N; Marr A; Kleikamp G; Maleszka A; Zittermann A; Körfer R; Radu M; Krian A; Litmathe J; Gams E; Sezer O; Scheld H; Schiller W; Welz A; Dohmen G; Autschbach R; Slottosch I; Wahlers T; Neuhäuser M; Jöckel KH; Jakob H
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):840-5. PubMed ID: 19327506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in patients with peripheral vascular disease after percutaneous coronary intervention and coronary artery bypass graft surgery.
    O'Rourke DJ; Quinton HB; Piper W; Hernandez F; Morton J; Hettleman B; Hearne M; Nugent W; O'Connor GT; Malenka DJ;
    Ann Thorac Surg; 2004 Aug; 78(2):466-70; discussion 470. PubMed ID: 15276497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery.
    Bonaros N; Hennerbichler D; Friedrich G; Kocher A; Pachinger O; Laufer G; Bonatti J
    J Thorac Cardiovasc Surg; 2009 Apr; 137(4):846-52. PubMed ID: 19327507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.
    Brener SJ; Lytle BW; Casserly IP; Schneider JP; Topol EJ; Lauer MS
    Circulation; 2004 May; 109(19):2290-5. PubMed ID: 15117846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery.
    Ward HB; Kelly RF; Thottapurathu L; Moritz TE; Larsen GC; Pierpont G; Santilli S; Goldman S; Krupski WC; Littooy F; Reda DJ; McFalls EO
    Ann Thorac Surg; 2006 Sep; 82(3):795-800; discussion 800-1. PubMed ID: 16928485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
    van Domburg RT; Lemos PA; Takkenberg JJ; Liu TK; van Herwerden LA; Arampatzis CA; Smits PC; Daemen J; Venema AC; Serruys PW; Bogers AJ
    Eur Heart J; 2005 Apr; 26(7):675-81. PubMed ID: 15637087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
    Pan W; Pintar T; Anton J; Lee VV; Vaughn WK; Collard CD
    Circulation; 2004 Sep; 110(11 Suppl 1):II45-9. PubMed ID: 15364837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification with cardiac troponin I in patients undergoing elective coronary artery bypass surgery.
    Thielmann M; Massoudy P; Neuhäuser M; Knipp S; Kamler M; Marggraf G; Piotrowski J; Jakob H
    Eur J Cardiothorac Surg; 2005 May; 27(5):861-9. PubMed ID: 15848327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).
    Feldman DN; Gade CL; Slotwiner AJ; Parikh M; Bergman G; Wong SC; Minutello RM;
    Am J Cardiol; 2006 Nov; 98(10):1334-9. PubMed ID: 17134624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population.
    Monteiro P;
    Circulation; 2006 Jul; 114(1 Suppl):I467-72. PubMed ID: 16820620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Previous percutaneous coronary interventions increase mortality and morbidity after coronary surgery.
    Mannacio V; Di Tommaso L; De Amicis V; Lucchetti V; Pepino P; Musumeci F; Vosa C
    Ann Thorac Surg; 2012 Jun; 93(6):1956-62. PubMed ID: 22520830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
    Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ;
    Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of drug-eluting stents and coronary artery bypass surgery for the treatment of multivessel coronary disease: three-year follow-up results from a single institution.
    Li Y; Zheng Z; Xu B; Zhang S; Li W; Gao R; Hu S
    Circulation; 2009 Apr; 119(15):2040-50. PubMed ID: 19349321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study.
    van Domburg RT; Takkenberg JJ; Noordzij LJ; Saia F; van Herwerden LA; Serruys PW; Bogers AJ
    Ann Thorac Surg; 2005 May; 79(5):1563-9. PubMed ID: 15854934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts.
    Upadhya B; Applegate RJ; Sane DC; Deliargyris EN; Kutcher MA; Gandhi SK; Baki TT; Call JT; Little WC
    Am J Cardiol; 2005 Aug; 96(4):515-8. PubMed ID: 16098303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.